HIGHLIGHTS
- who: Jinxiao Li and colleagues from the Second Military Medical University, China have published the research: Integrated network pharmacology and experimental verification to investigate the mechanisms of YYFZBJS against colorectal cancer via CDK1/PI3K/Akt signaling, in the Journal: (JOURNAL)
- what: The aim of this paper is to investigate the effect of compound prescription on CRC.
- how: Non-normally distributed data were compared using nonparametric rank sum test. p and amplt0.05 indicated statistically significant differences. The publicly available data indicated that among the core target proteins the levels of CDKN1A CCND1 CDK1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.